Experts say that surgical robots or robot doctors will be conducting one in three operations in the US in the next five years. The surgical robots are estimated to multiply two folds by 2021, with surgeons guiding mechanical them on comp…
BMI View: Moldova's pharmaceutical market presents very limited opportunities for multinational
drugmakers, in comparison to its neighbours in Eastern Europe. The country's small total market size and
its reliance on out-of-pocket payments highlight the challenges it poses. Moreover, continued economic
weakness and negative demographic trends will limit growth prospects.
Headline Expenditure Projections
? Pharmaceuticals: MDL5.83bn (USD310mn) in 2015 to MDL6.23bn (USD322mn) in 2016; 6.7% in
local currency terms and 3.8% in US dollar terms. Forecast unchanged from previous quarter.
? Healthcare: MDL12.32bn (USD654mn) in 2015 to MDL13.27bn (USD686mn) in 2015; +7.7% in local
currency terms and 4.8% in US dollar terms. Forecast unchanged from previous quarter.